BioCentury
ARTICLE | Clinical News

AST-OPC1: Phase I/IIa data

September 12, 2016 7:00 AM UTC

Researchers at Keck Medicine of the University of Southern California reported data from 1 patient with a cervical SCI in the open-label, dose-escalation, U.S. Phase I/IIa SCiStar trial showing that ...